Have you used our Patient Portal yet?
Search Rx Local on your web browser or download Rx Local today on the App Store or Google Play
Smith Pharmacy Logo

Patient Resources

Get Healthy!

  • Posted April 9, 2025

Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis

Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.

Health News is provided as a service to Smith Pharmacy site users by HealthDay. Smith Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags

Our family is here to care for your family!

Site Navigation

Contact Us

Smith Pharmacy
1800 Freedom Road, Unit D, Little Chute, WI 54140
(920) 788-8888 - (920) 788-8883
Toll-Free (866) 238-0974
visa mastercard amex discover FSAHSAApple PaySamsung Pay

2025 © All Rights Reserved. Privacy Policy